No significant associations were found between mutations and tumor size, tumor grade, lymph node metastasis, ER status, PR status, HER2 status, and adjuvant therapy in the total 892 patients (Table 1). The gene discussed is ESR1; the disease is metastatic malignant neoplasm in the lymph nodes.